Peter S Garcia's Net Worth

$5.62 Million

Estimate Recalculated Apr 18, 2024 03:51PM EST

Who is Peter S Garcia?

Peter S Garcia has an estimated net worth of $5.62 Million. This is based on reported shares across multiple companies, which include Marina Biotech, Inc., BIOTIME INC, ALX ONCOLOGY HOLDINGS INC, DURECT CORP, PDL BIOPHARMA, INC., and NUVELO INC.

SEC CIK

Peter S Garcia's CIK is 0001188956

Past Insider Trading and Trends

2015 was Peter S Garcia's most active year for acquiring shares with 9 total transactions. Peter S Garcia's most active month to acquire stocks was the month of July. 2021 was Peter S Garcia's most active year for disposing of shares, totalling 32 transactions. Peter S Garcia's most active month to dispose stocks was the month of July. 2017 saw Peter S Garcia paying a total of $483,246.11 for 237,669 shares, this is the most they've acquired in one year. In 2021 Peter S Garcia cashed out on 186,128 shares for a total of $6,522,359.48, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Marina Biotech, Inc. (ATRX) No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
5K
$0.60
$3,000.00
5K
Mar 31 - Aug 26
Form 4
—
0
—
—
0
Oct 14
Form 4
—
0
—
—
0
Jul 13
Form 3
—
0
—
—
0
No matching records found

BIOTIME INC (LCTX) Snapshot price: $1.05

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 20
Form 4
+250.00%
5K
$4.68
$23,378.50
7K
Mar 19
Form 4
∞
2K
$4.17
$8,340.00
2K
Nov 29
Form 3
—
0
—
—
0
No matching records found

ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.03

CHIEF FINANCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+29.29%
25K
—
—
110.35K
Feb 14
Form 4
-2.17%
-1.89K
$15.04
-$28,470.72
85.35K
Dec 29
Form 4
+58.46%
32K
—
—
86.74K
Jul 25
Form 4
-1.59%
-887.00
$7.34
-$6,510.58
54.74K
Jun 30
Form 4
-1.64%
-893.00
$11.07
-$9,885.60
53.72K
Dec 29
Form 4
+110.78%
29K
—
—
55.18K
Aug 5
Form 4
+158.18%
15K
$4.49
$67,304.99
24.48K
Feb 7
Form 4
—
0
$29.76
-$371,298.83
9.33K
Scheduled
Oct 18
Form 4
—
0
$41.61
-$958,400.21
9.33K
Scheduled
Sep 16 - Sep 17
Form 4
—
0
$39.12
-$4,203,961.78
9.33K
Scheduled
Aug 23
Form 4
—
0
$35.16
-$621,498.67
9.33K
Scheduled
Aug 17
Form 4
—
0
—
—
0
Jul 30
Form 4
+204.27%
6.13K
$4.08
$25,002.24
9.13K
Jan 28
Form 4
∞
3K
$19.00
$57,000.00
3K
Jul 21
Form 4
—
0
—
—
0
Jul 16
Form 3
—
0
—
—
0
No matching records found

DURECT CORP (DRRX) Snapshot price: $0.7128

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Dec 13
Form 3
—
0
—
—
0
No matching records found

PDL BIOPHARMA, INC. No price found

Vice President, CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
—
0
—
—
0
Mar 28
Form 4
—
0
—
—
0
Mar 28
Form 4
-50.55%
-230.00K
$3.02
-$10,730.06
225.03K
Dec 27
Form 4
—
0
—
—
0
Sep 25
Form 4
—
0
—
—
0
Jun 8
Form 4
-3.77%
-17.82K
—
—
455.02K
Dec 15
Form 4
+5.58%
25K
$1.98
$49,401.35
472.84K
Mar 24
Form 4
+90.43%
212.67K
$2.04
$433,844.76
447.84K
Mar 4
Form 4
-0.81%
-1.92K
—
—
235.17K
Dec 13
Form 4
+4.40%
10K
$3.00
$29,950.00
237.09K
Aug 9
Form 4
+80.17%
101.05K
$3.22
$325,384.22
227.09K
Jan 26
Form 4
+13.51%
15K
$3.50
$52,444.50
126.04K
Dec 14 - Dec 15
Form 4
+15.82%
15.17K
$4.95
$75,086.55
111.04K
Sep 29
Form 4
+26.36%
20K
$5.83
$116,501.98
95.87K
Aug 13 - Aug 14
Form 4
+76.34%
32.85K
$7.62
$250,294.14
75.87K
Jan 28
Form 4
+242.15%
30.45K
$8.22
$250,299.00
43.02K
Apr 10
Form 4
∞
12.57K
$8.35
$105,001.25
12.57K
May 23
Form 3
—
0
—
—
0
No matching records found